| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |